One-Stage Hepatectomy for Bilateral Liver Metastasis After Portal Embolization: Tumor Behavior of the Non-embolized Contralateral Lobe

Résumé fourni par la source

Background Two-stage hepatectomy is a well-known strategy for bilobar liver metastases, "cleaning" the future liver remnant (FLR) in the first stage, using portal vein embolization (PVE), and performing a major hepatectomy in the second stage. We used an alternative approach, performing PVE, to continue chemotherapy and perform liver resection. We describe our experience emphasizing liver hypertrophy and the tumor behavior of the contralateral liver metastasis. Methods Non-concurrent cohort study. Patients who underwent PVE before liver resection for bilobar metastases were included. Pre-PVE variables, post-PVE volumetry, variation of metastasis diameter in the FLR, perioperative variables, and overall survival were evaluated. Results Fifteen patients were included. Neoadjuvant chemotherapy was given in 14 patients (93.3%). Median FLR pre- and post-PVE were 20.4% and 31.5%. The median degree of hypertrophy was 46.2%. Median kinetic growth rate was 1.9% per week. The metastasis diameter decreased or was maintained in 11 patients (73.3%) after PVE. Twelve (80%) underwent R0 resection. Major postoperative morbidity occurred in two patients (13.3%); no early mortality was reported. Conclusions One-stage hepatectomy after PVE effectively achieves an adequate FLR, with contralateral tumor growth absent in most cases. This allows the continuation of chemotherapy during the hypertrophy period and achieves R0 resection of bilobar metastasis.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.